Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Results from the Great Britain AML Real World Evidence (ARC) Initiative - a Centre-Based Chart Review Study to Assess Treatment Outcomes of Venetoclax for the Treatment of Acute Myeloid Leukemia

Jenny O'Nions, Gerardo Errico, Lajos Floro, Vidhya Murthy, Connor Sweeney, Harpreet Kaur, Unmesh Mohite, Robert Ayto, Caroline Alvares, Aaron D. Goldberg, Kathryn Moulton, Hanna Kew, Ewa Kalinowska, Yanqing Xu, Paresh Vyas

Blood (2024) 144 (Supplement 1): 7932.

https://doi.org/10.1182/blood-2024-209926

Published: 2024

Journal Articles

Extracellular Microvesicle Cytokines Secreted from Bone Marrow Mesenchymal Cells Mediate Proliferative and Survival Advantage in Acute Myeloid Leukaemia

Michelle Lazenby, BSc, Oliver G. Ottmann, MD, Keith Wilson, FRCPath, MRCP, MBBS, Caroline Alvares, MBBS, PhD, Joanna Zabkiewicz, PhD

Blood (2018) 132 (Supplement 1): 2744.

https://doi.org/10.1182/blood-2018-99-113342

Published: 2018

Journal Articles

Adipogeneis in the Bone Marrow Microenvironment Confers a Proliferative Advantage in Residual Leukaemic Cell Populations in Acute Myeloid Leukaemia after Allogeneic Stem Cell Transplantation

Felicity May, BSc, Caroline Alvares, MBBS, PhD, Oliver G. Ottmann, MD, Joanna Zabkiewicz, PhD

Blood (2018) 132 (Supplement 1): 2580.

https://doi.org/10.1182/blood-2018-99-114443

Published: 2018

Journal Articles

Bone Marrow Stromal Cells Mediate Adhesion Based Drug Resistance in Acute Myeloid Leukaemia through Reciprocal Feedback of the β-Catenin/CD44 Signalling Axis

Lihui Zhuang, PhD MSc, BSc, Richard Darley, PhD, Oliver G. Ottmann, MD, Joanna Zabkiewicz, PhD, Caroline Alvares, MBBS, PhD

Blood (2018) 132 (Supplement 1): 2776.

https://doi.org/10.1182/blood-2018-99-113811

Published: 2018

Journal Articles

Pacritinib Suppresses Leukemic Outgrowth from FLT3-ITD Positive Stroma-Adherent Primary AML Cells

Ceri Marrin, MBBCh, Gareth Edwards, PhD, Steven Knapper, DM BMBCh, Alan K. Burnett, MDFRCP, Joanna Zabkiewicz, PhD, Caroline Alvares, MB BS PhD

Blood (2014) 124 (21): 270.

https://doi.org/10.1182/blood.V124.21.270.270

Published: 2014

Journal Articles

The Tyrosine Kinase Inhibitor TK258 Differentially Targets Proliferating Human Hematopoietic Progenitor Cells but Does Not Eliminate the Quiescent Fraction.

Caroline Alvares, Ian Titley, Mel Greaves, Michael Potter, Lyndal Kearney, Gareth Morgan, Kerol Bartolovic

Blood (2007) 110 (11): 3356.

https://doi.org/10.1182/blood.V110.11.3356.3356

Published: 2007

Journal Articles

Incidence of Second Malignant Neoplasms (SMN) after Haematopoetic Stem Cell Transplant.

Samar Kulkarni, MRCP, Michael Potter, MRCPath, Mark Ethell, PRCPath, Radovan Saso, PhD, Jennifer Treleaven, FRCPath, Joy Brennan, BSc, Pawel Kaczmarek, MRCP, Prashant Hiwarkar, MRCP, Pamala Kanagasabapathy, MRCP, Caroline Alvares, MRCPath, Clive Horton, PhD, Raymond Powles, FRCP, Frank Saran, FRCR, Gareth Morgan, FRCPath

Blood (2006) 108 (11): 551.

https://doi.org/10.1182/blood.V108.11.551.551

Published: 2006

Journal Articles

Lymphocyte Count on Day 56 Predicts for Reduced Risk of Infection Related Mortality Following Non-Myeloablative Allogeneic Haematopoietic Stem Cell Transplantation.

Caroline Alvares, MRCPath, Samar Kulkarni, MRCP, Pawel Kaczmarek, PhD, Radovan Saso, PhD, Helena Woods, Joy Brennan, BSc, Clive Horton, PhD, Jennifer Treleaven, FRCPath, Mark Ethell, MRCPath, Claire Dearden, MRCPath, Gareth Morgan, FRCPath, Michael Potter, FRCPath

Blood (2006) 108 (11): 5324.

https://doi.org/10.1182/blood.V108.11.5324.5324

Published: 2006

Journal Articles

Pregnancy Outcome Following Haematopoietic Stem Cell Transplantation.

Samar Kulkarni, MRCP, Mark Ethell, MRCPath, Jennifer Treleaven, FRCPath, Radovan Saso, PhD, Joy Brennan, BsC, Pawel Kaczmarek, PhD, Caroline Alvares, MRCPATH, Clive Horton, PhD, Frank Saran, FRCR, Pamala Kanagasabapathy, MRCP, Prashant Hiwarkar, MRCP, Stella Appiah-Cubi, MRCP, Moez Dungarwala, MRCP, Raymond Powles, FRCP, Gareth Morgan, FRCPath, Michael Potter, FRCPath

Blood (2006) 108 (11): 3367.

https://doi.org/10.1182/blood.V108.11.3367.3367

Published: 2006

Journal Articles

A Comparative Analysis of Outcomes in Primary Myelodysplastic Syndrome (MDS) and Therapy-Related MDS Reveals Two Subgroups with Differing Risk Profiles: Implications for the Application of a Prognostic Classification.

Caroline Alvares, Sue Ashley, Radovan Saso, Gita Patel, Amrana Qureshi, Michael Potter, Mark Ethell, Jennifer Treleaven, Claire Dearden, Gareth Morgan

Blood (2005) 106 (11): 2532.

https://doi.org/10.1182/blood.V106.11.2532.2532

Published: 2005

Journal Articles

Recipient CMV Seropositivity Predicts Relapse Post Allogeneic Transplantation in Children.

Roslin Zuha, MRCP, MRCPATH, Alex Gatt, MRCP, MRCPATH, Caroline Alvares, MRCP, MRCPATH, Clive Horton, Gita Patel, Mark Ethell, MRCP, MRCPATH, Michael Potter, FRCP, FRCPATH

Blood (2004) 104 (11): 5140.

https://doi.org/10.1182/blood.V104.11.5140.5140

Published: 2004

NARROW

Results from the Great Britain AML Real World Evidence (ARC) Initiative - a Centre-Based Chart Review Study to Assess Treatment Outcomes of Venetoclax for the Treatment of Acute Myeloid Leukemia

Extracellular Microvesicle Cytokines Secreted from Bone Marrow Mesenchymal Cells Mediate Proliferative and Survival Advantage in Acute Myeloid Leukaemia

Adipogeneis in the Bone Marrow Microenvironment Confers a Proliferative Advantage in Residual Leukaemic Cell Populations in Acute Myeloid Leukaemia after Allogeneic Stem Cell Transplantation

Bone Marrow Stromal Cells Mediate Adhesion Based Drug Resistance in Acute Myeloid Leukaemia through Reciprocal Feedback of the β-Catenin/CD44 Signalling Axis

Pacritinib Suppresses Leukemic Outgrowth from FLT3-ITD Positive Stroma-Adherent Primary AML Cells

The Tyrosine Kinase Inhibitor TK258 Differentially Targets Proliferating Human Hematopoietic Progenitor Cells but Does Not Eliminate the Quiescent Fraction.

Incidence of Second Malignant Neoplasms (SMN) after Haematopoetic Stem Cell Transplant.

Lymphocyte Count on Day 56 Predicts for Reduced Risk of Infection Related Mortality Following Non-Myeloablative Allogeneic Haematopoietic Stem Cell Transplantation.

Pregnancy Outcome Following Haematopoietic Stem Cell Transplantation.

A Comparative Analysis of Outcomes in Primary Myelodysplastic Syndrome (MDS) and Therapy-Related MDS Reveals Two Subgroups with Differing Risk Profiles: Implications for the Application of a Prognostic Classification.

Recipient CMV Seropositivity Predicts Relapse Post Allogeneic Transplantation in Children.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only